Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapy
Crossref DOI link: https://doi.org/10.1073/pnas.2507821122
Published Online: 2025-05-19
Published Print: 2025-05-27
Update policy: https://doi.org/10.1073/pnas.cm10313
Mandelboim, Ofer
Porgador, Angel
Version of Record valid from 2025-05-19
Publication History
Published: 2025-05-19
